Nutriband, Inc. (NTRB)
7.28
-0.08
(-1.09%)
USD |
NASDAQ |
Oct 02, 16:00
7.50
+0.22
(+3.02%)
After-Hours: 20:00
Nutriband Profit Margin (Quarterly) : -201.3% for July 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -201.3% |
| April 30, 2026 | -286.6% |
| January 31, 2026 | -241.6% |
| October 31, 2025 | -1.12K% |
| July 31, 2025 | -321.3% |
| April 30, 2025 | -208.1% |
| January 31, 2025 | -858.7% |
| October 31, 2024 | -211.0% |
| July 31, 2024 | -385.2% |
| April 30, 2024 | -464.7% |
| January 31, 2024 | -358.6% |
| October 31, 2023 | -411.4% |
| July 31, 2023 | -126.4% |
| April 30, 2023 | -212.9% |
| January 31, 2023 | -318.4% |
| October 31, 2022 | -174.0% |
| Date | Value |
|---|---|
| July 31, 2022 | -227.7% |
| April 30, 2022 | -144.4% |
| January 31, 2022 | -766.1% |
| October 31, 2021 | -555.4% |
| July 31, 2021 | -243.3% |
| April 30, 2021 | -72.69% |
| January 31, 2021 | -647.0% |
| October 31, 2020 | -10.87% |
| July 31, 2020 | -267.7% |
| April 30, 2020 | -345.2% |
| January 31, 2020 | -4.82K% |
| October 31, 2019 | -912.0% |
| July 31, 2019 | -601.6% |
| April 30, 2019 | -296.2% |
| January 31, 2019 | -625.2% |
| October 31, 2018 | -300.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -102.3% |
| Return on Assets | -88.52% |
| Return on Invested Capital | -98.72% |
| Gross Profit Margin (Quarterly) | 40.73% |
| Operating Margin (Quarterly) | -203.6% |
| Return on Net Operating Assets | -231.8% |